
Anti-inflammatory effects of the selective phosphodiesterase 3 inhibitor, cilostazol, and antioxidants, enzymatically-modified isoquercitrin and α-lipoic acid, reduce dextran sulphate sodium-induced colorectal mucosal injury in mice
Keywords: ALA; α-lipoic acid; cAMP; cyclic adenosine monophosphate; cGMP; cyclic guanosine monophosphate; CZ; cilostazol; DAI; disease activity index; DSS; dextran sodium sulphate; EMIQ; enzymatically modified isoquercitrin; H&E; haematoxylin and eosin; IBD; infla